Hyperbaric Oxygen Treatment In Patients With White Matter Hyperintensities On Magnetic Resonance Imaging and Neurologic Deficits
Description:
Consecutively enrolled patients will be assigned to hyperbaric oxygen or hyperbaric air by
random number. Physicians supervising the hyperbaric treatments and the treating technicians,
the evaluating neurologist, and the interpreter of the MRIs will be blinded regarding patient
treatment status. All patients who receive placebo will be offered treatment with hyperbaric
oxygen.
Condition:
Neurological Impairments
Treatment:
Start Date:
July 2007
Sponsor:
St. Luke’s Hospital, Chesterfield, Missouri
For More Information:
https://clinicaltrials.gov/show/NCT00497432